FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593516807> ?p ?o ?g. }

• W2593516807 abstract "Alpha-1 antitrypsin (AAT) is an acute phase protease inhibitor. Currently, the only available treatment for patients with COPD caused by AAT deficiency is replacement therapy, requiring weekly infusions of human plasma-derived AAT. While AAT has shown potential when inhaled to treat both emphysema and cystic fibrosis, the oxidation susceptibility of methionine residues at positions 351 and 358 in the reactive site loop have led to difficulties in maintaining AAT activity and stability when aerosolized. Using a novel cucumber mosaic virus-based inducible transient expression system, we have produced a biobetter plant recombinant AAT (prAAT) in Nicotiana benthamiana . This variant replaces the oxidation-susceptible methionine residue at position 358 with a valine residue to increase resistance to oxidation. N. benthamiana plants were vacuum infiltrated as detached leaves with two strains of Agrobacterium tumefaciens : one carrying the biobetter AAT gene and one carrying a gene for the tomato bushy stunt virus p19 viral RNA silencing suppressor driven by a constitutive cauliflower mosaic virus 35S promoter. Leaves were incubated in humidity chambers at 20°C in the dark for 6 days before flash freezing in liquid nitrogen, grinding, and protein extraction in a 20 mM Tris, 150 mM NaCl, and 0.01% (v/v) Tween-80 AAT stability buffer. Purification was achieved using Alpha-1 Antitrypsin Select Affinity Chromatography (GE Healthcare) with a 58.1±8.1% yield of active AAT. Activity of purified AAT was confirmed via a band shift in a Western blot after incubation with excess porcine pancreatic elastase, however, degradation of prAAT was also observed in all purified extracts. Purified prAAT was tested against an analytical standard (Calbiochem) and Prolastin-C (Griffols), a common therapeutic formulation of human AAT, to determine its activity and oxidation resistance. 41±11% of purified prAAT and 71.9±5.5% of Prolastin-C showed activity against porcine pancreatic elastase as determined by a residual elastase activity inhibitory assay. Under oxidation with 48.9 mM H 2 O 2 for 60 minutes at room temperature, prAAT was found to retain 102.8±20.4% of its original anti-elastase activity, while Prolastin-C retained 13.8±5.0% anti-elastase activity and analytical standard AAT retained 11.6±7.5% anti-elastase activity. Future work will include determinations of oxidation resistance to OCl – /HOCl and development of more optimal isolation and purification processes." @default.
• W2593516807 created "2017-03-16" @default.
• W2593516807 creator A5017260886 @default.
• W2593516807 creator A5023719098 @default.
• W2593516807 creator A5049514965 @default.
• W2593516807 creator A5055377716 @default.
• W2593516807 creator A5085666265 @default.
• W2593516807 date "2016-11-01" @default.
• W2593516807 modified "2023-09-27" @default.
• W2593516807 title "Plant-Based Production, Purification, and Characterization of Oxidation-Resistant Alpha-1 Antitrypsin" @default.
• W2593516807 doi "https://doi.org/10.1016/j.freeradbiomed.2016.10.156" @default.
• W2593516807 hasPublicationYear "2016" @default.
• W2593516807 type Work @default.
• W2593516807 sameAs 2593516807 @default.
• W2593516807 citedByCount "1" @default.
• W2593516807 countsByYear W25935168072018 @default.
• W2593516807 crossrefType "journal-article" @default.
• W2593516807 hasAuthorship W2593516807A5017260886 @default.
• W2593516807 hasAuthorship W2593516807A5023719098 @default.
• W2593516807 hasAuthorship W2593516807A5049514965 @default.
• W2593516807 hasAuthorship W2593516807A5055377716 @default.
• W2593516807 hasAuthorship W2593516807A5085666265 @default.
• W2593516807 hasConcept C104317684 @default.
• W2593516807 hasConcept C153911025 @default.
• W2593516807 hasConcept C185592680 @default.
• W2593516807 hasConcept C204241405 @default.
• W2593516807 hasConcept C2776162087 @default.
• W2593516807 hasConcept C2780562374 @default.
• W2593516807 hasConcept C40767141 @default.
• W2593516807 hasConcept C55493867 @default.
• W2593516807 hasConcept C86803240 @default.
• W2593516807 hasConceptScore W2593516807C104317684 @default.
• W2593516807 hasConceptScore W2593516807C153911025 @default.
• W2593516807 hasConceptScore W2593516807C185592680 @default.
• W2593516807 hasConceptScore W2593516807C204241405 @default.
• W2593516807 hasConceptScore W2593516807C2776162087 @default.
• W2593516807 hasConceptScore W2593516807C2780562374 @default.
• W2593516807 hasConceptScore W2593516807C40767141 @default.
• W2593516807 hasConceptScore W2593516807C55493867 @default.
• W2593516807 hasConceptScore W2593516807C86803240 @default.
• W2593516807 hasLocation W25935168071 @default.
• W2593516807 hasOpenAccess W2593516807 @default.
• W2593516807 hasPrimaryLocation W25935168071 @default.
• W2593516807 hasRelatedWork W158525432 @default.
• W2593516807 hasRelatedWork W1974185456 @default.
• W2593516807 hasRelatedWork W1980444857 @default.
• W2593516807 hasRelatedWork W1982315657 @default.
• W2593516807 hasRelatedWork W2007867445 @default.
• W2593516807 hasRelatedWork W2008625862 @default.
• W2593516807 hasRelatedWork W2057499599 @default.
• W2593516807 hasRelatedWork W2083770632 @default.
• W2593516807 hasRelatedWork W2095308539 @default.
• W2593516807 hasRelatedWork W2169126907 @default.
• W2593516807 hasRelatedWork W2171261170 @default.
• W2593516807 hasRelatedWork W2327992315 @default.
• W2593516807 hasRelatedWork W2329932351 @default.
• W2593516807 hasRelatedWork W2409477017 @default.
• W2593516807 hasRelatedWork W2416377437 @default.
• W2593516807 hasRelatedWork W2753797509 @default.
• W2593516807 hasRelatedWork W2766180628 @default.
• W2593516807 hasRelatedWork W2794919396 @default.
• W2593516807 hasRelatedWork W54652309 @default.
• W2593516807 hasRelatedWork W2461156869 @default.
• W2593516807 isParatext "false" @default.
• W2593516807 isRetracted "false" @default.
• W2593516807 magId "2593516807" @default.
• W2593516807 workType "article" @default.